EZH2 contributes to the response to PARP inhibitors through its PARP-mediated poly-ADP ribosylation in breast cancer

H. Yamaguchi, Y. Du, K. Nakai, M. Ding, S. S. Chang, J. L. Hsu, J. Yao, Y. Wei, L. Nie, S. Jiao, W. C. Chang, C. H. Chen, Y. Yu, G. N. Hortobagyi, M. C. Hung

Research output: Contribution to journalArticlepeer-review

31 Scopus citations

Fingerprint

Dive into the research topics of 'EZH2 contributes to the response to PARP inhibitors through its PARP-mediated poly-ADP ribosylation in breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences